文献速递胃肠外科围术期管理与 ERAS

食管癌根治性食管切除术后常规胸导管切除的预后:基于日本综合登记12,237例患者的倾向性匹配分析

Prognosis of Patients with Esophageal Carcinoma After Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan.
PubMed 文献 · Ann Surg · 2023-04-06

该研究基于日本食管癌综合登记库2007–2012年间12,237例接受食管切除术的患者,采用严格倾向性评分匹配比较胸导管切除与保留组的预后、围术期结局及初始复发模式。匹配后每组1,638例c-Stage I-IV患者,两组5年总生存率和病因特异性生存率无显著差异,胸导管切除组获取的纵隔淋巴结更多且淋巴结复发更少,但远处转移器官总数显著更多。结论为胸导管切除未改善生存,不推荐预防性胸导管切除。

要点

  • 胸导管切除组与保留组5年总生存率分别为57.5%和55.2%,无显著差异。
  • 胸导管切除组获取纵隔淋巴结30枚 vs 保留组21枚(P<0.0001)。
  • 胸导管切除组淋巴结复发376例 vs 保留组450例(P=0.0029)。

核心结论

  • 胸导管切除未改善食管癌患者生存。
  • 尽管获取更多淋巴结,胸导管切除导致远处转移器官数多于胸导管保留。
  • 因此不推荐对食管癌患者行预防性胸导管切除。

研究设计与样本

  • 基于日本食管癌综合登记库2007–2012年间12,237例接受食管切除术患者的分析。
  • 采用严格倾向性评分匹配比较胸导管切除组与保留组的预后、围术期结局和初始复发模式。
  • 匹配协变量包括食管切除术年份和其他器官原发癌病史。
  • 匹配后每组1,638例c-Stage I-IV患者。

主要发现

  • 匹配后胸导管切除组与保留组5年总生存率分别为57.5%和55.2%,无显著差异。
  • 匹配后胸导管切除组与保留组5年病因特异性生存率分别为65.6%和63.4%,无显著差异。
  • 胸导管切除组获取纵隔淋巴结30枚 vs 保留组21枚(P<0.0001)。
  • 胸导管切除组淋巴结复发376例 vs 保留组450例(P=0.0029)。
  • 胸导管切除组远处转移器官总数499 vs 保留组421(P=0.0024)。

临床怎么用

  • 基于该登记分析,食管癌患者行预防性胸导管切除未显示生存获益,且与远处转移器官数增多相关,不应推荐。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To clarify whether routine thoracic duct (TD) resection improves the prognosis of patients with esophageal cancer after radical esophagectomy. SUMMARY OF BACKGROUND DATA: Although TD resection can cause nutritional disadvantage and immune suppression, it has been performed for the resection of surrounding lymph nodes. METHODS: We analyzed 12,237 patients from the Comprehensive Registry of Esophageal Cancer in Japan who underwent esophagectomy between 2007 and 2012. TD resection and preservation groups were compared in terms of prognosis, perioperative outcomes, and initial recurrent patterns using strict propensity score matching. Particularly, the year of esophagectomy and history of primary cancer of other organs were added as covariates. RESULTS: After propensity score matching, 1638 c-Stage I-IV patients participated in each group. The 5 year overall survival and cause-specific survival rates were 57.5% and 65.6% in the TD-resected group and 55.2% and 63.4% in the TD-preserved group, respectively, without significant differences. The TD-resected group had significantly more retrieved mediastinal nodes (30 vs 21, P < 0.0001) and significantly fewer lymph node recurrence (376 vs 450, P = 0.0029) compared with the TD-preserved group. However, the total number of distant metastatic organs was significantly greater in TD-resected group than in the TD-preserved group (499 vs 421, P = 0.0024). CONCLUSIONS: TD resection did not improve survival in patients with esoph-ageal cancer. Despite having retrieved more lymph nodes, TD resection caused distant metastases in more organs compared to TD preservation. Hence, prophylactic TD resection should not be recommended in patients with esophageal cancer.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Oshikiri T, Numasaki H, Oguma J, et al. Prognosis of Patients with Esophageal Carcinoma After Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients Based on the Comprehensive Registry of Esophageal Cancer in Japan. Ann Surg. 2023. PMID: 34913902. doi:10.1097/SLA.0000000000005340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。